{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T11:22:45Z","timestamp":1790508165919,"version":"4.1.0"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,11,17]],"date-time":"2020-11-17T00:00:00Z","timestamp":1605571200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI18\/00164"],"award-info":[{"award-number":["PI18\/00164"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI19\/01896"],"award-info":[{"award-number":["PI19\/01896"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["CA 160525"],"award-info":[{"award-number":["CA 160525"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","award":["817884"],"award-info":[{"award-number":["817884"]}],"id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003425","name":"Departamento de Educaci\u00f3n, Gobierno de Navarra","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003425","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004435","name":"Universidad de Navarra","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004435","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy Oncolytics"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.omto.2020.11.003","type":"journal-article","created":{"date-parts":[[2020,11,20]],"date-time":"2020-11-20T11:29:23Z","timestamp":1605871763000},"page":"23-33","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Local administration of IL-12 with an HC vector results in local and metastatic tumor control in pediatric osteosarcoma"],"prefix":"10.1016","volume":"20","author":[{"given":"Marta","family":"Zalacain","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"Bunuales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc\u00eda","family":"Marrodan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Labiano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marisol","family":"Gonzalez-Huarriz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naiara","family":"Martinez-V\u00e9lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginia","family":"Laspidea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Montse","family":"Puigdelloses","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Garc\u00eda-Moure","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela","family":"Gonzalez-Aparicio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rub\u00e9n","family":"Hernandez-Alcoceba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7520-7351","authenticated-orcid":false,"given":"Marta M.","family":"Alonso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Pati\u00f1o-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omto.2020.11.003_bib1","first-page":"83","article-title":"Childhood and adolescent cancer statistics, 2014","volume":"64","author":"Ward","year":"2014","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.omto.2020.11.003_bib2","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1200\/JCO.2002.20.3.776","article-title":"Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols","volume":"20","author":"Bielack","year":"2002","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.omto.2020.11.003_bib3","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1002\/jbmr.77","article-title":"Osteosarcoma","volume":"25","author":"Gorlick","year":"2010","journal-title":"J.\u00a0Bone Miner. Res."},{"key":"10.1016\/j.omto.2020.11.003_bib4","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1002\/pbc.24429","article-title":"Children\u2019s Oncology Group\u2019s 2013 blueprint for research: bone tumors","volume":"60","author":"Gorlick","year":"2013","journal-title":"Pediatr. Blood Cancer"},{"key":"10.1016\/j.omto.2020.11.003_bib5","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S1359-6101(01)00032-6","article-title":"Interleukin-12 in anti-tumor immunity and immunotherapy","volume":"13","author":"Colombo","year":"2002","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.omto.2020.11.003_bib6","doi-asserted-by":"crossref","first-page":"4677","DOI":"10.1158\/1078-0432.CCR-07-0776","article-title":"Interleukin-12: biological properties and clinical application","volume":"13","author":"Del Vecchio","year":"2007","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.omto.2020.11.003_bib7","first-page":"1183","article-title":"Phase I trial of subcutaneous recombinant human interleukin-12 in patients with advanced renal cell carcinoma","volume":"4","author":"Motzer","year":"1998","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.omto.2020.11.003_bib8","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1200\/JCO.2004.04.059","article-title":"Phase I trial of intratumoral injection of an adenovirus encoding interleukin-12 for advanced digestive tumors","volume":"22","author":"Sangro","year":"2004","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.omto.2020.11.003_bib9","doi-asserted-by":"crossref","first-page":"400","DOI":"10.3390\/cells9020400","article-title":"Oncolytic Virus Encoding a Master Pro-Inflammatory Cytokine Interleukin 12 in Cancer Immunotherapy","volume":"9","author":"Nguyen","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.omto.2020.11.003_bib10","doi-asserted-by":"crossref","first-page":"E3643","DOI":"10.3390\/ijms21103643","article-title":"High-capacity adenoviral vectors: Expanding the scope of gene therapy","volume":"21","author":"Ricobaraza","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.omto.2020.11.003_bib11","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1053\/j.gastro.2003.10.075","article-title":"Prolonged and inducible transgene expression in the liver using gutless adenovirus: a potential therapy for liver cancer","volume":"126","author":"Wang","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.omto.2020.11.003_bib12","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1136\/gut.2010.211722","article-title":"Oxaliplatin in combination with liver-specific expression of interleukin 12 reduces the immunosuppressive microenvironment of tumours and eradicates metastatic colorectal cancer in mice","volume":"60","author":"Gonzalez-Aparicio","year":"2011","journal-title":"Gut"},{"key":"10.1016\/j.omto.2020.11.003_bib13","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.jconrel.2017.10.032","article-title":"Adaptation of vectors and drug-inducible systems for controlled expression of transgenes in the tumor microenvironment","volume":"268","author":"Poutou","year":"2017","journal-title":"J.\u00a0Control. Release"},{"key":"10.1016\/j.omto.2020.11.003_bib14","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1038\/gt.2015.45","article-title":"Safety and antitumor effect of oncolytic and helper-dependent adenoviruses expressing interleukin-12 variants in a hamster pancreatic cancer model","volume":"22","author":"Poutou","year":"2015","journal-title":"Gene Ther."},{"key":"10.1016\/j.omto.2020.11.003_bib15","first-page":"4066","article-title":"Interleukin (IL)-12 and IL-12 gene transfer up-regulate Fas expression in human osteosarcoma and breast cancer cells","volume":"61","author":"Lafleur","year":"2001","journal-title":"Cancer Res."},{"key":"10.1016\/j.omto.2020.11.003_bib16","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1158\/1078-0432.CCR-1245-02","article-title":"Interleukin-12 enhances the sensitivity of human osteosarcoma cells to 4-hydroperoxycyclophosphamide by a mechanism involving the Fas\/Fas-ligand pathway","volume":"10","author":"Duan","year":"2004","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.omto.2020.11.003_bib17","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1002\/cncr.21744","article-title":"Intranasal interleukin-12 gene therapy enhanced the activity of ifosfamide against osteosarcoma lung metastases","volume":"106","author":"Duan","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.omto.2020.11.003_bib18","first-page":"3462","article-title":"Aerosol gene therapy with PEI: IL-12 eradicates osteosarcoma lung metastases","volume":"9","author":"Jia","year":"2003","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.omto.2020.11.003_bib19","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1126\/science.270.5238.908.a","article-title":"IL-12 Deaths: Explanation and a Puzzle","volume":"270","author":"Cohen","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.omto.2020.11.003_bib20","doi-asserted-by":"crossref","first-page":"12006","DOI":"10.1073\/pnas.1307935110","article-title":"Multifaceted oncolytic virus therapy for glioblastoma in an immunocompetent cancer stem cell model","volume":"110","author":"Cheema","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omto.2020.11.003_bib21","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.ccell.2017.07.006","article-title":"Macrophage Polarization Contributes to Glioblastoma Eradication by Combination Immunovirotherapy and Immune Checkpoint Blockade","volume":"32","author":"Saha","year":"2017","journal-title":"Cancer Cell"},{"key":"10.1016\/j.omto.2020.11.003_bib22","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1038\/s41467-017-01385-8","article-title":"Re-designing Interleukin-12 to enhance its safety and potential as an anti-tumor immunotherapeutic agent","volume":"8","author":"Wang","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omto.2020.11.003_bib23","doi-asserted-by":"crossref","first-page":"179","DOI":"10.2217\/imt.15.109","article-title":"Gene therapy approaches against cancer using in\u00a0vivo and ex\u00a0vivo gene transfer of interleukin-12","volume":"8","author":"Hernandez-Alcoceba","year":"2016","journal-title":"Immunotherapy"},{"key":"10.1016\/j.omto.2020.11.003_bib24","doi-asserted-by":"crossref","first-page":"eaaw5680","DOI":"10.1126\/scitranslmed.aaw5680","article-title":"Regulatable interleukin-12 gene therapy in patients with recurrent high-grade glioma: Results of a phase 1 trial","volume":"11","author":"Chiocca","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.omto.2020.11.003_bib25","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.ccell.2019.10.006","article-title":"Intratumor Adoptive Transfer of IL-12 mRNA Transiently Engineered Antitumor CD8+ T Cells","volume":"36","author":"Etxeberria","year":"2019","journal-title":"Cancer Cell"},{"key":"10.1016\/j.omto.2020.11.003_bib26","doi-asserted-by":"crossref","first-page":"103711","DOI":"10.1016\/j.cellimm.2017.10.011","article-title":"The contribution of immune infiltrates and the local microenvironment in the pathogenesis of osteosarcoma","volume":"343","author":"Heymann","year":"2019","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.omto.2020.11.003_bib27","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1158\/1078-0432.CCR-10-2047","article-title":"Tumor-infiltrating macrophages are associated with metastasis suppression in high-grade osteosarcoma: a rationale for treatment with macrophage activating agents","volume":"17","author":"Buddingh","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.omto.2020.11.003_bib28","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.intimp.2017.01.006","article-title":"Tim3\/Gal9 interactions between T\u00a0cells and monocytes result in an immunosuppressive feedback loop that inhibits Th1 responses in osteosarcoma patients","volume":"44","author":"Li","year":"2017","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.omto.2020.11.003_bib29","doi-asserted-by":"crossref","first-page":"105818","DOI":"10.1016\/j.intimp.2019.105818","article-title":"SDF-1\/CXCR4 axis facilitates myeloid-derived suppressor cells accumulation in osteosarcoma microenvironment and blunts the response to anti-PD-1 therapy","volume":"75","author":"Jiang","year":"2019","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.omto.2020.11.003_bib30","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1245\/s10434-014-4001-2","article-title":"Improved survival in osteosarcoma patients with atypical low vascularization","volume":"22","author":"Kunz","year":"2015","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.omto.2020.11.003_bib31","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1023\/A:1006767007547","article-title":"An orthotopic model of murine osteosarcoma with clonally related variants differing in pulmonary metastatic potential","volume":"18","author":"Khanna","year":"2000","journal-title":"Clin. Exp. Metastasis"},{"key":"10.1016\/j.omto.2020.11.003_bib32","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1038\/gt.2011.58","article-title":"Self-inactivating helper virus for the production of high-capacity adenoviral vectors","volume":"18","author":"Gonzalez-Aparicio","year":"2011","journal-title":"Gene Ther."},{"key":"10.1016\/j.omto.2020.11.003_bib33","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1089\/hum.2009.020","article-title":"Persistence of high-capacity adenoviral vectors as replication-defective monomeric genomes in\u00a0vitro and in murine liver","volume":"20","author":"Jager","year":"2009","journal-title":"Hum. Gene Ther."}],"container-title":["Molecular Therapy Oncolytics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2372770520301686?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2372770520301686?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T12:35:24Z","timestamp":1784723724000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2372770520301686"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":33,"alternative-id":["S2372770520301686"],"URL":"https:\/\/doi.org\/10.1016\/j.omto.2020.11.003","relation":{},"ISSN":["2372-7705"],"issn-type":[{"value":"2372-7705","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Local administration of IL-12 with an HC vector results in local and metastatic tumor control in pediatric osteosarcoma","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy Oncolytics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omto.2020.11.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s).","name":"copyright","label":"Copyright"}]}}